AVTX4:01 PMAvalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)avalotx.com
AVTX7:00 AMAvalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 CongressPresentation / Abstract • Phase 2EADV poster presentation Wed, Sep 30, 2026, 7:00 AM CESTavalotx.com
AVTX4:05 PMAvalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)avalotx.com
AVTX7:00 AMAvalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updatesavalotx.com